FOLD icon

Amicus Therapeutics

216 hedge funds and large institutions have $2.81B invested in Amicus Therapeutics in 2022 Q1 according to their latest regulatory filings, with 25 funds opening new positions, 64 increasing their positions, 87 reducing their positions, and 29 closing their positions.

New
Increased
Maintained
Reduced
Closed

more call options, than puts

Call options by funds: $ | Put options by funds: $

more ownership

Funds ownership:

less funds holding

Funds holding:

less first-time investments, than exits

New positions opened: | Existing positions closed:

14% less funds holding in top 10

Funds holding in top 10: 76 (-1)

19% less capital invested

Capital invested by funds: $3.48B → $2.81B (-$666M)

26% less repeat investments, than reductions

Existing positions increased: 64 | Existing positions reduced: 87

Holders
216
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
6
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$3.56M
Puts
$2.56M
Net Calls
Net Calls Change

Top Buyers

1 +$54.6M
2 +$33.9M
3 +$18.9M
4
State Street
State Street
Massachusetts
+$13.6M
5
PA
Perceptive Advisors
New York
+$9.44M

Top Sellers

1 -$19.4M
2 -$18.9M
3 -$17.2M
4
Two Sigma Investments
Two Sigma Investments
New York
-$11.2M
5
GH
Grosvenor Holdings
Illinois
-$11.1M
Name Holding Trade Value Shares
Change
Change in
Stake
101
$948K
102
$939K
103
$883K
104
$842K
105
$821K
106
$781K
107
$741K
108
$739K
109
$724K
110
$701K
111
$571K
112
$569K
113
$548K
114
$532K
115
$505K
116
$466K
117
$462K
118
$428K
119
$428K
120
$408K
121
$408K
122
$390K
123
$379K
124
$377K
125
$375K